Startups

Philly companies will spend more on software in 2017: report

The Federal Reserve Bank of Philadelphia released its 2017 Economic Outlook report, developed in partnership with the Chamber of Commerce for Greater Philadelphia.

The survey polled 146 Philly companies. (Photo by Roberto Torres)

Get those pitch decks ready, B2B software companies: according to the latest numbers from the Federal Reserve Bank of Philadelphia and the Chamber of Commerce for the Greater Philadelphia, Philly-area companies are projected to spend more money on software in 2017.

Based on data from 146 companies, the survey projects capital expenditures in equipment and software are expected to climb by at least 5 percent following a double-digit contraction in 2016 from the previous year.

Download the full report

The 2017 report was presented on Wednesday morning by Elif Sen, a senior economic analyst with the agency, during the Chamber’s annual Economic Outlook event. Sen, after introducing the disclaimer that her opinions were her own and not those of the Philadelphia Fed, depicted the overall outlook for 2017 as “positive.”

“Almost 64 percent of the respondents are optimistic that business activity at their companies will increase in 2017,” said Sen in a press release. “More than 47 percent reported that they expect to hire more full-time permanent employees in 2017.”

Companies: Federal Reserve Bank of Philadelphia / Chamber of Commerce for Greater Philadelphia
Engagement

Join our growing Slack community

Join 5,000 tech professionals and entrepreneurs in our community Slack today!

Donate to the Journalism Fund

Your support powers our independent journalism. Unlike most business-media outlets, we don’t have a paywall. Instead, we count on your personal and organizational contributions.

Trending

You've heard the term 'valuation' on 'Shark Tank.' What does it actually mean?

Piano raises $120M for biz analytics tools, with plans to hit $100M in revenue this year

Ecommerce founder reveals how her startup raised millions and won international acclaim

Does the Spark Therapeutics writedown undermine Philly’s biotech swagger?

Technically Media